Knuff & Co’s Quest Diagnostics DGX Stock Holding History

Knuff & Co’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-100	Closed	-$11K	–	168
2020 Q3	$11K	Buy	+100	New	+$11.8K	0.01%	163

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Knuff & Co's DGX Position: Q4 2020 in Review

Knuff & Co sold out of Quest Diagnostics (DGX) in Q4 2020, closing a stake of 100 shares — an estimated $11K sold.

Knuff & Co first reported a position in DGX in Q3 2020 and held it in 1 quarter. The position peaked at $11K in Q3 2020. 811 funds tracked by Wall St. Rank hold DGX as of Q4 2020.

Knuff & Co reported no remaining Quest Diagnostics position as of Q4 2020 after selling out during the quarter.
Knuff & Co sold 100 Quest Diagnostics shares in Q4 2020, an estimated $11K.
Knuff & Co first reported a position in Quest Diagnostics in Q3 2020 and held it in 1 quarter.
Knuff & Co's Quest Diagnostics position peaked at $11K in Q3 2020.
811 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2020.

Based on Knuff & Co's 13F filing for Q4 2020, filed 3 Feb 2021.